When starting Wegovy , your first week will primarily focus on allowing your body to adjust to the medication
[12] [13] The Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) continue to monitor the safety profile of GLP-1 agonists through routine pharmacovigilance
International Expansion The company is expanding internationally aggressively as well
And most were also able to drop their long-acting insulin, which is used to keep overnight blood sugar levels in check
Several studies have shown that complete withdrawal of an obesity treatment dose of a GLP-1RA without other structured care leads to weight regain in most people.2 However, it remains unclear whether lifelong treatment of obesity should always consist of GLP-1RAs at full obesity dosing or whether a range of alternative strategies can enable some subset of people with obesity to maintain their weight loss after a limited duration of initial treatment, followed by tapering, discontinuing, or off-ramping these agents." This paragraph from the article, I believe, sums up nicely what this means
Less common but more serious side effects can include pancreatitis, gallbladder problems, or kidney issues
